PEPFAR's annual planning process is done either at the country (COP) or regional level (ROP).
PEPFAR's programs are implemented through implementing partners who apply for funding based on PEPFAR's published Requests for Applications.
Since 2010, PEPFAR COPs have grouped implementing partners according to an organizational type. We have retroactively applied these classifications to earlier years in the database as well.
Also called "Strategic Areas", these are general areas of HIV programming. Each program area has several corresponding budget codes.
Specific areas of HIV programming. Budget Codes are the lowest level of spending data available.
Expenditure Program Areas track general areas of PEPFAR expenditure.
Subdivisions of Program Areas, these track general higher level sub-classifications of expenditure.
Subdivisions of Major categories, these are the most detailed expenditure data.
Cross-cutting attributions are areas of PEPFAR programming that contribute across several program areas. They contain limited indicative information related to aspects such as human resources, health infrastructure, or key populations programming. However, they represent only a small proportion of the total funds that PEPFAR allocates through the COP process. Additionally, they have changed significantly over the years. As such, analysis and interpretation of these data should be approached carefully. Learn more
PEPFAR sets targets using the Monitoring, Evaluation, and Reporting (MER) System - documentation for which can be found on PEPFAR's website at https://www.pepfar.gov/reports/guidance/. As with most data on this website, the targets here have been extracted from the COP documents. Targets are for the fiscal year following each COP year, such that selecting 2016 will access targets for FY2017. This feature is currently experimental and should be used for exploratory purposes only at present.
Years of mechanism: 2008
Management Sciences for Health (MSH) has been awarded the RPM Plus follow-on: Strengthening
Pharmaceutical Systems (SPS), therefore all RPM Plus activities for FY 2008 will be undertaken by SPS.
SPS will strengthen the pharmaceutical component of the Prevention of Mother-to-Child Transmission
(PMTCT) services at the facility level and the role of pharmacy personnel in promoting and supporting
PMTCT services. Three activities have been identified: 1) strengthening health personnel capacity to
support the PMTCT program, assisting with the review of National PMTCT standard treatment guidelines
(STGs); 2) monitoring of PMTCT commodities; and 3) improving management of patients to support
National Department of Health (NDOH) prevention efforts. The major emphasis area is needs assessment,
and minor emphasis areas include human resources, linkages with other sectors, logistics and training.
Target populations include women, infants, family planning clients, people living with HIV (PLHIV), policy
makers, national program staff, and public doctors, nurses, pharmacists, and other healthcare workers.
In South Africa, the implementation of PMTCT services is one of the key HIV and AIDS interventions, as
prevention remains the cornerstone of the country's response to HIV and AIDS. PMTCT services are
available through hospitals, midwife obstetric units, community health centers and primary healthcare
clinics. In 2003, RPM Plus received funds from the USAID Child Survival program to assist in strengthening
the "pharmaceutical component" of the PMTCT program. An in-depth analysis of existing policies and
practices was conducted and is being applied in collaboration with the National and all nine provincial
Departments of Health. SPS is also providing support to the NDOH Pharmaceutical Policy and Planning
Cluster (NDOH-PPP), and the Medicines Control Council (MCC) with the selection and review of the drug(s)
and regimen of choice for PMTCT.
ACTIVITIES AND EXPECTED RESULTS:
ACTIVITY 1: Strengthening health personnel capacity to support the PMTCT program
SPS will conduct provincial workshops for pharmacists, pharmacist's assistants and nurses to address
issues identified during the assessment of PMTCT services and will include an update to health staff on
recommended ART regimen(s) for pregnant women and the associated clinical pharmacology (i.e., drug of
choice, adverse-drug-event while on ART). The focus of the provincial workshops will be on training primary
healthcare (PHC) level workers, as PHC sites constitute one of the primary sites for prevention, and also
diagnosis, staging, referral and routine follow-up of HIV-infected patients. Quantification of PMTCT related
medicines and commodities will also be addressed during the training. Additional provincial workshops will
be conducted during FY 2008. The expansion of the National ARV program to the PHC level is anticipated
to take place during this period. A full comprehensive training program will be implemented in provinces and
local government authorities.
ACTIVITY 2: Technical assistance
SPS will continue the ongoing support provided to the NDOH Essential Drugs List Committee in reviewing
PMTCT drug(s) of choice and standard treatment guidelines (STGs), to the MCC on regulatory issues, and
to the NDOH PMTCT Task Force in planning implementation of the strategy. This activity also includes the
review and development of training modules to include new PMTCT STGs in the training conducted by SPS
(e.g., HIV and AIDS management and Pharmaceutical and Therapeutic Committee training). The review of
the National PHC EDL is underway and includes the review of PMTCT STGs. In FY 2008 SPS will continue
to provide support in the implementation of the recommendations that arose from the PMTC assessment
and National workshop.
ACTIVITY 3: Monitoring of PMTCT commodities and patient management
SPS will implement systems (manual and computerized) to monitor the use of PMTCT commodities and the
management of patients at PHC level. This includes the monitoring of distribution and use of cotrimoxazole,
nevirapine and/or AZT.
These activities contribute to the PEPFAR 2-7-10 goals by improving the quality of the PMTCT services
provided at the facility level.
MSH has been awarded the RPM Plus follow-on: Strengthening Pharmaceutical Systems (SPS), therefore
all RPM Plus activities for FY 2008 will be undertaken by SPS. SPS will assist the National Department of
Health TB sub-directorate to strengthen drug supply management for TB and more specifically the
management of TB patient on ARVs by training health workers supporting the TB program on clinical
pharmacology related to TB/HIV coinfection, and improving infection control, adherence monitoring, adverse
drug-event reporting, medication errors and referral system(s) at selected government institutions
(hospitals, community health centers, primary health care clinics). SPS will also train pharmacists on
estimating requirements for ARV and TB medicines. The major area of emphasis include training and task
shifting, as pharmacists and pharmacist assistants will take on greater roles in TB/HIV care.
RPM Plus has been working very closely with the National Department of Health Pharmaceutical Policy and
Planning Directorate since 2004 to support the delivery of pharmaceutical services at all levels (national,
provincial, district, institutional). This included training TB provincial coordinators (and pharmacists) on Drug
Supply Management for TB in collaboration with the National TB sub-directorate. The coexistence of TB
and HIV infections has made the treatment of patients on ARVs more complex and health personnel need
to be trained to manage it. Moreover, a national plan has been developed to address what has been
described as the "TB Crisis," making TB and HIV management a priority. The smear negative rate at the
end of treatment in South Africa, 51%, remains well below the WHO target of 85%. These smear positive
patients remain infective and continue to spread TB; people infected with HIV are particularly vulnerable to
acquiring TB. It therefore follows that against the background of the high HIV prevalence rate in South
Africa it is important to reduce the infectious reservoirs within the community. Currently only 63% of patients
complete their course of treatment and the South African Medical Research Council estimates that 6.7% of
previously treated patients are resistant. The financial burden of multidrug-resistant TB (MDR-TB) is
considerable -- the usual course of treatment costs approximately $60 while that of MDR is approximately
$3,500. In addition the social impact is considerable as these patients are hospitalized in isolation facilities
for long periods of time. Recently extensively drug-resistant (XDR-TB) has been identified in South Africa
which requires highly specialized treatment facilities and medicines. In December 2005, RPM Plus
published the "Managing Pharmaceuticals and Commodities for Tuberculosis; A Guide for National
Tuberculosis Programs". This publication was shared with the National TB sub-directorate and they have
expressed interest in using these guidelines to support their own program. All these activities will be
conducted in close collaboration with the directorates dealing with TB, HIV and AIDS and Quality Assurance
at the National level. The Department of Correctional Services and local governments have requested
support from SPS to strengthen the role of pharmacy personnel in supporting the TB program.
ACTIVITIES AND EXPECTED RESULTS:
ACTIVITY 1: Drug Supply Management for TB
RPM Plus has experience with ARV supply management in South Africa. As other projects are involved in
the actual patient care and medication administration, SPS will assure that the medications are where they
need to be and tracked appropriately. SPS will perform a similar function in the TB/HIV program area. In FY
2007 RPM Plus adapted the Drug Supply Management for TB training material they developed to include
topics related to the treatment of TB patients on ART. The training program covers clinical pharmacology
principles and other relevant issues such as: drug-to-drug interactions between Rifampicin and different
classes of ARVs; immune reconstitution inflammatory syndrome (IRIS); rationale for changing ART regimen
in the presence of TB; assessment of tolerance to TB drugs; increased toxicity; adherence to both ARV and
TB treatment; and counseling. One National and nine provincial workshops will be conducted for doctors,
pharmacists, and nurses involved in the management and implementation of the National TB program. The
integrated computerized drug supply management system developed by RPM Plus (RxSolution) will be
implemented at selected TB hospitals. The implementation of this system will assist these institutions in
providing data for the National TB indicators; this will also assist in validating the data captured on the
National Electronic TB Register (ETR) for these facilities and provide detailed information on patient
treatment. This activity will assist with the overall monitoring and evaluation of the TB program.
ACTIVITY 2: Adherence to Treatment and Rational Use of Medicines
SPS will directly assist selected institutions that are providing TB treatment to implement adherence
monitoring systems for TB patients on ARVs. This will include recognition, treatment and reporting of
adverse drug events (ADR) and medication errors reporting, and quality improvement strategy. The
institutions will be selected in consultation with provincial DOH, and will most likely be located in Eastern
Cape, KwaZulu-Natal, and Gauteng - priority provinces in the National TB Crisis Plan. SPS will also
strengthen the referral system for TB patients to access ARVs. SPS will provide assistance to the Eastern
Cape and Mpumalanga provincial Departments of Health to develop and pilot a standardized adherence
package for TB patients. The ARV adherence assessment tool recently developed by RPM Plus will be
adapted by SPS for use in TB patients by both the patient as well as the treatment supporter. Training will
be provided to staff in the application of the adherence package for MDR and XDR-TB patients. Finally
technical support will be provided to the MDR-TB facilities in order to improve referral mechanisms, comply
with regulatory requirement pertaining to XDR treatments, reporting and quality improvement of medication
errors and the reporting and management of adverse drug events. In 2006 RPM Plus medication error
surveillance systems identified an ongoing trend of prescribing errors in hospitalized TB patients. In order to
further define the required rational prescribing interventions, Drug Utilization Reviews (DUR) will be
conducted at selected sites. The findings will then be used in the planning and execution of a TB rational
prescribing intervention at the hospital level. This is significant because an increasing number of patients
who are HIV-infected require initiation of TB treatment at the hospital level. The piloting of the DUR tool has
revealed deficiencies in the pharmacy discharge procedures and patients are sent home with treatment
without the necessary referral to DOTS. SPS will develop guidelines to improve referral to DOTS supporter.
In the Eastern Cape SPS will use the Medicines Information center at Rhodes university to provide patient
and prescribing information for MDR and XDR-TB medications. Furthermore this service will provide
support to pharmacists and prescribers in assessing drug interactions. SPS will be training pharmacy
personnel (and other health workers) on the management of both TB and HIV/AIDS (see ARV Services) to
Activity Narrative: support the national effort in integrating TB and HIV programs within the national health services.
ACTIVITY 3: Quantification
The management of TB in HIV-infected patients is critical since TB is the number one opportunistic infection
and the leading cause of death for HIV-infected clients - making the availability of TB medicines critical.
SPS will train provincial and district pharmacists in the use of morbidity-based quantification models for the
quantification of TB medicines using TB National Standard Treatment Guidelines (STGs). Pharmacists will
be trained. This activity will also assist in monitoring prescription trends against National TB STGs.
ACTIVITY 4: TB/HIV Infection Control
TB infection control, given the high burden of HIV co-morbidity, has been identified as a critical area
needing support. RPM Plus has developed an Infection Control Assessment Tool (ICAT) which will be used
to assess infection control practices in these settings. SPS will train health workers on implementing TB
infection control measures and procedures at facilities where TB/HIV services are provided. As a follow-up
an Infection Control improvement plan will be developed to address gaps identified using the ICAT.
Opportunities to work with other PEPFAR partners will be explored. This is done in collaboration with the
National Department for Quality Assurance.
All these activities contribute to the PEPFAR 2-7-10 goals by improving the treatment of patients with TB
and HIV infection and supporting the national effort in dealing with the "TB crisis".
With FY 2008 PEPFAR funds, Management Sciences for Health's (MSH) Strengthening Pharmaceutical
Services (SPS) project will continue and expand activities already underway in South Africa to support the
effective management of antiretroviral (ARV) medicines. SPS will continue to influence drug provision
positively by improving estimation of needs for ARV, opportunistic infection (OI), and sexually transmitted
infection (STI) drugs; implementing systems to support drug supply management activities and to monitor
drug availability at the institution and district levels; and developing a highly skilled pool of pharmacy
personnel to manage them. The objective is also to strengthen the use of Drug Supply Management
Information for government facilities at all levels. The emphasis areas are human capacity development,
and wraparound programs. Target populations include National AIDS Control Programme staff, other
national and provincial Department of Health (DOH) staff, nurses, pharmacists and pharmacist assistants.
Opportunities for collaboration with the Partnership for Supply Chain Management will be explored.
Since FY 2004, RPM Plus has been working in close collaboration with the National Department of Health
(NDOH) Pharmaceutical Policy and Planning unit, and provincial and local government pharmaceutical
services to support the delivery of pharmaceutical services at all levels (national, provincial, district, and
institutional). The following activities are a continuation of the activities initiated since FY 2004. Systems and
models for drug supply management have been developed and tested. In FY 2008, SPS will continue the
implementation of these systems on a larger scale and will monitor the impact on the delivery of
antiretroviral treatment (ART) at accredited sites (including down referral and primary healthcare sites).
These activities have received the full support of the NDOH Pharmaceutical Policy and Planning unit and
the Provincial Pharmaceutical Services. The Department of Correctional Services has requested SPS
support in strengthening the delivery of pharmacy services.
ACTIVITY 1: Drug Supply Management Information System
RPM Plus developed an integrated, computerized drug supply management information system
(RxSolution) to assist hospital, community health center and district level pharmacy personnel to manage
drug supply activities from hospital bulk stores to the patients through satellite pharmacies (outpatient and
inpatient), wards and down referral clinics. This supports the management of purchase orders, inventory,
issues to clients (satellite pharmacies, wards, and primary healthcare (PHC) clinics), and budgets. It also
supports the management of patient records, prescriptions and quantities dispensed directly to the patient
or through down referral sites. Data links with electronic patient registers have been implemented. The
RxSolution system is currently used in five provinces (Eastern Cape, Mpumalanga, Gauteng, North West
and Free State) at government and local government sites. In the Eastern Cape alone, the existing sites
have contributed to the treatment of 15,000 patients. RxSolution is used at hospitals to support the down-
referral of patients to a primary healthcare institution, typically patients on chronic medication or stabilized
ARV patients. The main objectives are to reduce the burden on the hospital and decrease the cost for the
patient. Some of the ARV sites using RxSolution have shown great improvement in the management of
their supplies for ART and non-ART medicines. As a result, more ART-accredited sites (hospitals, wellness
centers) have requested to use this system. As SPS scales up, different approaches will be used to ensure
adequate support and maintenance. In the Free State, the government has hired a pharmacist/IT manager
to support RxSolution. SPS will develop an interface between RxSolution and the new provincial warehouse
management system. This application is expected to be deployed to additional sites and other provinces.
During FY 2007 SPS is expected to develop an interface between RxSolution and Therapy Edge, used by
Right to Care, and pilot it at Right to Care (and other) ART sites. This activity is done in collaboration with
the Supply Chain Management System (SCMS) Project. Additional joint sites will be identified during FY
2008. RxSolution is currently used in over 100 sites throughout South Africa, Swaziland and Lesotho with
RPM Plus/SPS support.
The SPS system goes beyond ARV management. All medicines used at the facilities can be tracked,
including drugs for TB and opportunistic infections, as well as any other type of commodity (medical
supplies, lab reagents, etc.). The dispensing module of the system allows providers to monitor any lab test
(and results) performed for any type of patient. It also allows tracking loss-to-follow-up, defaulters, etc.
Lastly, the system is also able to monitor adherence to treatment. Treatment can be classified as first line
and/or second line, and can be referenced by the International Statistical Classification of Diseases and
Related Health Problems, 10th Revision (ICD-10) as well. All this information should assist in monitoring the
overall program and identifying any trends (including prescribed regimen vs. standard regimen). Overall the
system can thus provide a mix of logistic (availability, consumption, expenditures) and clinical (treatment,
treatment outcomes, use, and disease and prescribing patterns) data.
ACTIVITY 2: Support National/Provincial Quantification
SPS is constantly improving and developing new models to estimate and monitor drug needs using
morbidity and consumption data. These models are specifically tailored to the South African National
Standard Treatment Guidelines (STGs) for HIV and AIDS, STIs, OIs, other priority diseases and post-
exposure prophylaxis (PEP). RPM Plus has trained provincial staff responsible for the submission of
provincial estimates, provincial pharmaceutical warehouse managers and pharmacists responsible for the
procurement of ARVs and medicines used for the treatment of OIs and STIs at the institutional level
(hospital, community health center and district). In FY 2008, training in quantifying ARV-related drug
requirements will continue through national and provincial workshops. These workshops provide an
opportunity to establish a national network to discuss and report consumption trends and issues, to maintain
a dialogue with representatives from the pharmaceutical industry and to prepare reports for the National
Comprehensive Care, Management and Treatment of HIV and AIDS forum. Training in quantification needs
to be an ongoing function, especially in the public sector in South Africa where community service
pharmacists are often in charge of the ARV pharmacy for their year of service, then leave the public sector
for the private sector without plans for succession. The quantification models will be shared with the SCMS
and joint training workshops will be conducted for PEPFAR partners.
Activity Narrative: ACTIVITY 3: Data for Decision Making
With FY 2008 PEPFAR funding, SPS will continue the training of pharmacy personnel in using their data for
decision making to ensure that the increasing demand for medicines required for the care and treatment of
HIV and AIDS and other related programs is met, and to monitor national drug supply management
indicators. This also provides an opportunity to strengthen the working relationship between pharmacists
and other program managers. Individuals from the Provincial Pharmaceutical Services and from the
National Pharmaceutical Policy and Planning unit will be trained. SPS will assist provinces with the national
reporting system. All the activities above will indirectly support all HIV-infected clients who will be receiving
care and treatment at government ARV accredited sites through the improvement of the delivery of
These activities support PEPFAR 2-7-10 goals as well as the vision outlined in South Africa's Five-Year
Strategy by facilitating the national ARV rollout.
Management Sciences for Health's (MSH) Strengthening Pharmaceutical Services (SPS) project will
support the South African Government's (SAG) Operational Plan for Comprehensive HIV and AIDS Care,
Management and Treatment (CCMT). SPS improves the reliable provision of ARV services and other
related services; support monitors progress towards compliance with pharmaceutical legislation and ARV
accreditation requirements for provincial health facilities; trains pharmacists and pharmacist assistants in
basic principles of HIV and AIDS management; trains health personnel in conducting medicine use
evaluations, using adherence to antiretroviral treatment (ART) measurement tools; supports the review of
national standard treatment guidelines (STGs) for HIV and AIDS, TB, STI and other diseases; strengthens
the provincial implementation of pharmaceutical therapeutic committees and medicine information centers;
and strengthens pharmacovigilance reporting. The emphasis areas are human capacity development and
wraparound programs. Target populations include National AIDS Control Program staff, policy makers,
public and private health care workers (especially pharmacists), people living with HIV (PLHIV) and their
families, OVC and the general population of children, youth and adults. SPS will work in all nine provinces
to support national, provincial and local government pharmaceutical services as well as the Department of
Correctional Services. Opportunities for collaboration with the Supply Chain Management System (SCMS)
Project will be explored.
Pharmaceutical Policy and Planning (NDOH-PPP) Unit, and provincial and local government
pharmaceutical services to support the delivery of pharmaceutical services at all levels. The following
activities are a continuation of the activities initiated since FY 2004. Systems and models have been
developed and tested. In FY 2008, SPS will continue the implementation of these on a larger scale and
monitor the impact on the delivery of ART at accredited sites. These activities have received the full support
of the NDOH-PPP unit and the provincial pharmaceutical services.
ACTIVITY 1: Pharmaceutical Services Delivery
Since 2004 RPM Plus has provided assistance to all provinces in monitoring progress towards compliance
with the SAG legislative requirements that relate to the delivery of pharmaceutical services as well as the
applicable standards for the accreditation of health institutions (hospitals, community health centers) to
provide ART. This activity addresses issues related to infrastructure, human resources, equipment and
systems. Thus far activities have included the development of a monitoring tool and the conducting of
reviews in the provinces and Metros. A national workshop was held in 2007 which was attended by
representatives of all provinces, the national office, local governments and correctional services. In FY 2008
the work will continue with the focus being on strengthening pharmaceutical services within the legislative
framework. Activities will include assistance with the development of policies and procedures at all levels,
development and implementation of models of service delivery to support the provision of quality service to
patients with HIV and AIDS, TB and other diseases, capacity building in the areas of governance,
pharmaceutical care and monitoring and evaluation of pharmaceutical service delivery.
ACTIVITY 2: Pharmacovigilance
The CCMT recognizes the importance of strengthening pharmacovigilance measures to ensure the safe
and effective use of ARVs and other medicines used in HIV and AIDS patients. The identification, diagnosis,
management and reporting of HIV medication-related adverse effects are critical. RPM Plus has worked
with the national and provincial health departments and other key stakeholders to develop training materials
to meet this need. SPS will conduct training programs to build capacity by providing skills and knowledge to
HIV and AIDS program managers and the Medicine Regulatory Authority (MRA) on the principles of public
health pharmacovigilance and the safety of antiretroviral agents. In addition, SPS will assist and advise
facility-based HIV and AIDS programs on the planning and implementation of pharmacovigilance
surveillance activities, with subsequent follow-up at the provincial and national levels; support scientific
research relating to key drug safety issues identified in the region; assist in the communication of
information obtained from pharmacovigilance systems and research managed by the national and local HIV
and AIDS programs; and establish networks linking pharmacovigilance programs in the region with each
other in order to encourage information exchange and skills transfer.
ACTIVITY 3: ART Adherence
Since August 2005, RPM Plus has been working in collaboration with the national and Eastern Cape HIV
and AIDS units and other key stakeholders to improve treatment outcomes and prevent resistance to ARVs
through the development of ART adherence measurement tools and determining best practices. Following
the successful development and piloting of an adherence assessment tool the National Department of
Health requested RPM to roll out the tool in May 2007. Clinical staff (doctors, nurses and pharmacists) will
be trained by SPS in providing: patient education on HIV, AIDS and ART; provider education on HIV, AIDS
and ART; psychological and social screening of patients to assess readiness for treatment; and support
services to facilitate resolution of barriers to adherence. These efforts will also contribute to the overall
strengthening of the health system as medication adherence monitoring and support measures are generic
tools that may be applied to settings providing treatment for other chronic diseases. In the long-term the
goal is to develop a network of expertise and facilities, and establish South Africa as a Regional
Pharmaceutical Technical Collaboration Centre (RPTCC) for ARV adherence-related matters.
ACTIVITY 4: STGs and Rational Drug Use
The revised edition of the South Africa adult and pediatric STGs for the hospital level has just been
published. These STGs include new chapters on HIV and AIDS care and treatment. SPS will assist the
NDOH in reviewing these STGs and the primary health care EDL on an ongoing basis, and the provinces in
promoting these new STGs. SPS will also conduct provincial workshops on rational drug use; strengthen
provincial, district and institutional pharmaceutical and therapeutic committees (PTCs); assist with the
Activity Narrative: development of provincial formularies; train staff in basic principles of pharmacy economics and the use of
evidence-based principles for drug selection; and implement provincial medicines information centers.
Through these activities SPS will also assist the NDOH in reviewing their infection control policies and
ACTIVITY 5: Down Referral and Integration of Services
There is a need to scale-up access to ART. One strategy of the NDOH is to down refer stabilized patients
on ART to their nearest primary health care (PHC) facility. The other long-term approach is to initiate the
treatment at PHC level. SPS will support these two critical initiatives by assisting in the development,
implementation and strengthening of down referral systems as well as the integration of the provision of
ART with the supply of medicine for other conditions treated at PHC level. RPM Plus has included a down
referral module in their integrated drug supply management system (RxSolution).
ACTIVITY 6: Training of Pharmacy Personnel from ART sites (and others)
There is an urgent need to build capacity among pharmacy personnel to manage patients on ARVs. The
anticipated deployment of the National AIDS treatment program at PHC level, make this activity a priority.
RPM Plus has developed a 5-day HIV and AIDS training program specifically for Pharmacists and
Pharmacist's Assistants. This training program is being accredited by the South African Pharmacy Council.
In FY 2006 over 1200 health personnel have been trained. SPS will expand this program to PHC Level
Pharmacy personnel and to other counterparts such as Correctional Services.
ACTIVITY 7: Technical Assistance to Local Counterparts
Since its inception in 2003, RPM Plus has been requested on a regular basis by government (e.g.
Medicines Control Council) and non-government organizations (e.g. the South African Pharmacy Council,
the South African Qualifications Authority) to provide ad hoc technical assistance for a wide range of
services such as the development of staffing norms for pharmaceutical services, accreditation of facilities,
development of standards of pharmacy practice, the review/revision of the scope of practice and
competency standards for persons involved in the provision of pharmaceutical services, implementation of
legislation to reduce the price of medicine and improve medicine availability to communities, (including
ARVs and medicine used in the treatment of co-morbidities) and the development and implementation of
public-private partnership service level agreements. In FY 2008 SPS will continue to provide technical
assistance in these areas as well as other emerging issues such as pharmacy care and monitoring and
All these activities will build South African capacity and support the improvement of health services. This will
contribute to the achievement the overall PEPFAR goals of reaching 10 million people with care and 2
million with treatment.